Run by Roger Perlmutter and backed by more than $1 billion in private funding, Eikon will use the IPO proceeds to advance a ...

This special report details the Central Bureau of Investigation's (CBI) probe into the deadly Karur stampede, which resulted ...

This clinical-stage biotech specializing in blood disorders reported a notable insider sale amid strong recent stock performance.

From lab space and coffee bars to jobs and long-term returns, mid-tier life sciences hubs may be better positioned than the biggest biotech boomtowns.

CG Oncology develops cretostimogene via rolling BLA, phase 3 PIVOT-006 data in 1H 2026, and $680M cash into 2028. Find out ...

Veteran immunologist and former Pfizer R&D leader joins Circurna to advance its circular RNA therapeutic platform ...

The rebrand reflects the organization’s strategic evolution from a procurement-focused provider to a comprehensive, ...

Enzymes are the molecular machines that power life; they build and break down molecules, copy DNA, digest food, and drive ...

An Instagram post about the last two northern white rhinos references a scenario conservationists have warned us about for ...

Learn how conglomerates manage risks, offer diversification, and impact investments. Explore the advantages, disadvantages, ...

Pancreatic organoids reveal how lumen shape is controlled by the balance between cell proliferation, internal pressure, and epithelial permeability.

As of Friday, January 09, Rigel Pharmaceuticals, Inc.’s RIGL share price has dipped by 5.01%, which has investors questioning ...